India has sent more than 23 COVID-19 CRORE vaccines to more than 50 countries worldwide in the last two years under the initiative of the Maitri vaccine, Data shows.In 2020, when the world holds hands to find prevention for Pandemic, all eyes are on India – the power plant known from the making of the vaccine.
According to data collected by the Observer Research Foundation vaccine tracker, around 17.30 Crore doses have been sold commercially while 4.45 Crore has been sent through a commitment to the Covax platform that is supported by WHO.This vaccine dose has been distributed in 33 countries in Africa, nine countries in Asia and two each in America (Bolivia and Nikaragua), Oceania (Papua Nugini and the Solomon Islands) and West Asia (Syria and Yemen).
India produces 60 percent of the world vaccine and accounts for 60-80 percent of the procurement of the UN annual vaccine. Even before the outbreak of Covid, Indian companies have helped for years to produce and distribute vaccines to the world. “India’s extraordinary ability in producing cost-effective vaccines against Covid-19 has been proven through its own massive immunization program,” Mona, who led the Covid Trackers in ORF, told News18.com.
“While excessive dependence at the Serum Institute at Covishield India initially injured the chain of global vaccine supply in 2021, even now, although the producers of various and more number of vaccine candidates, the vaccine made-in-India remains the most trusted in This world . The Serum Institute alone has supplied nearly 150 Covishield doses to Covax, “he said, while analyzing further that Quad’s partnership had also decided to distribute 1 billion Biological C Corbevax E doses in the Indo-Pacific region.The only concern, he said, at this point is that Corbevax is the only vaccine approved in India for the age group 15-17, which might create competitive priorities for the country (in terms of giving lower priorities to exports).
Covax supported by WHO was formed in April 2020 to ensure a global fair vaccine distribution, especially to low and lower-income countries that do not have infrastructure or the capacity to produce anti-bound drugs internally.India stopped Covax’s commitment under the Maitri vaccine program when the second wave of destructive Covid-19 struck in April 2021. It was done to prioritize the Indian population attached to the virus given the deadly impact of the delta waves. That was then continued in November 2021.
According to the latest data available from the Ministry of External Affairs (updated until June 22, 2022), a dose of 4.46 Crore has been sent to the Covax Alliance.Most of the covax doses have been distributed to African countries (dose of 3.3 crore). The top three recipients in Africa are Nigeria (96 Lakh), Ethiopia (42 Lakh), and Ghana (26 Lakh).In the Indian environment, Nepal has received a dose of 63 Lakh, followed by Bangladesh (43 Lakh), Afghanistan (4.7 Lakh), Sri Lanka (2.6 Lakh), and Maldives (10,000).
“Only Covishield sent through Covax. Other vaccines, the doses of Covaxin and Covovax are only distributed through commercial agreements and grants, “added Mona, while showing that other neighbors such as Myanmar and Bhutan have also received Indian vaccines through commercial agreements and grants.SII based in Pune-who produces Covishield-is the largest vaccine maker in the world with the number of doses produced and sold globally. The 50 -year -old company produces 1.5 billion doses every year before the start of Pandemi and specializes in various vaccines such as polio, diphtheria, tetanus, pertussis, and BCG.